Kezar Life Sciences And Everest Medicines Collaborate To Bring Zetomipzomib To Patients With Lupus Nephritis And More Across Greater China, South Korea, And Southeast Asia
Portfolio Pulse from Benzinga Newsdesk
Kezar Life Sciences has partnered with Everest Medicines to bring Zetomipzomib to patients with Lupus Nephritis across Greater China, South Korea, and Southeast Asia.
September 21, 2023 | 5:16 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Kezar Life Sciences' partnership with Everest Medicines to distribute Zetomipzomib in Asia could potentially increase its market reach and revenues.
The partnership with Everest Medicines allows Kezar Life Sciences to distribute its product, Zetomipzomib, in a large and growing market - Asia. This could potentially increase the company's market reach and revenues, which could positively impact its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100